LIEBERMAN GERALD M 4

Accession 0001178913-23-003988

CIK 0001638097other

View on SEC.gov Company Profile

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 5:00 PM ET

Size

13.1 KB

Accession

0001178913-23-003988

Insider Transaction Report

Form 4

Period: 2023-12-22

Entera Bio Ltd.ENTX

LIEBERMAN GERALD M

Director

Transactions

Purchase
Ordinary Shares, par value NIS 0.0000769 per share
2023-12-22$0.71/sh+23,952$17,006→ 226,961 total
Purchase
Warrants (right to buy)
2023-12-22$0.13/sh+23,952$2,994→ 23,952 total
Exercise: $1.00From: 2023-12-22Exp: 2028-12-22→ Ordinary Shares, par value NIS 0.0000769 per share (23,952 underlying)

Holdings

Ordinary Shares, par value NIS 0.0000769 per share
(indirect: By Trust)
6,200
Ordinary Shares, par value NIS 0.0000769 per share
(indirect: By Trust)
6,200
Ordinary Shares, par value NIS 0.0000769 per share
(indirect: By Trust)
6,200
Ordinary Shares, par value NIS 0.0000769 per share
(indirect: By Trust)
6,200

Footnotes (6)

[F1]The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share ("Ordinary Shares"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules.
[F2]The Reporting Person's aggregate amount of Ordinary Shares in the Reporting Person's previous filings was inadvertently overstated by 11,200 shares. The aggregate amount has been properly adjusted in this Form 4.
[F3]These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
[F4]These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
[F5]These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
[F6]These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Documents

1 file

4
zk2330700.xmlPrimary

Issuer

Entera Bio Ltd.

CIK 0001638097

→

Entity typeother

Related Parties

filerCIK 0001234346

Filing Metadata

Form type: 4
Filed: Dec 26, 7:00 PM ET
Accepted: Dec 27, 5:00 PM ET
Size: 13.1 KB

View on SEC.gov